Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Go back to Novo Nordisk trims price for blockbuster obesity drug as competition heats up| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.19 +1.48 (3.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.71 | 52 Week High | $59.00 | |||
| Open | $41.98 | 52 Week Low | $32.80 | |||
| Day High | $43.44 | P/E | N/A | |||
| Day Low | $41.96 | EPS | $0.00 | |||
| Volume | 12,974,379 | |||||
